Girls with Seizures Due to the c.320A>G Variant in ALG13 Do Not Show Abnormal Glycosylation Pattern on Standard Testing
- PMID: 25732998
- PMCID: PMC4486277
- DOI: 10.1007/8904_2015_416
Girls with Seizures Due to the c.320A>G Variant in ALG13 Do Not Show Abnormal Glycosylation Pattern on Standard Testing
Abstract
A girl with early onset severe epilepsy, developmental delay, intellectual disability, visual maturation delays, and feeding problems was without a diagnosis despite an extensive genetic and metabolic evaluation. She initially manifested infantile spasms which responded to high-dose ACTH. Seizures seemed to resolve, but then at age 5, she developed complex partial seizures resistant to antiepileptics that responded to a ketogenic diet. Additional features included visual impairment, hypotonia, reflux, and severe feeding problems requiring a G-tube. She was referred to the Geisinger Health System whole-genome sequencing clinical research program. A variant in the X-linked gene ALG13 (c.320A->G p. 107 N->S) was identified. Four additional girls from three published exome sequencing studies were found to have the identical c.320A>G variant in ALG13. All presented with early onset severe epilepsy and intellectual disability. Three of the five exhibited visual impairment and possible developmental regression. A boy with a variant in ALG13 presented with a severe congenital disorder of glycosylation type Is. Glycosylation studies in the case reported here were normal; none of the other girls reported in the literature have had glycosylation studies. X-inactivation studies have not been done. The N107 residue and the surrounding region - MNNHQ - are highly conserved across species and are found in a presumed functional domain of this glycotransferase superfamily. The consistent clinical presentation of a severe phenotype in girls coupled with identical variants in an X-linked gene strongly suggests a critical position effect. Negative glycosylation studies in one individual suggest the possibility of a new mechanism requiring investigation.
Similar articles
-
Exome sequence identified a c.320A > G ALG13 variant in a female with infantile epileptic encephalopathy with normal glycosylation and random X inactivation: Review of the literature.Eur J Med Genet. 2017 Oct;60(10):541-547. doi: 10.1016/j.ejmg.2017.07.014. Epub 2017 Aug 1. Eur J Med Genet. 2017. PMID: 28778787 Review.
-
ALG13-CDG with Infantile Spasms in a Male Patient Due to a De Novo ALG13 Gene Mutation.JIMD Rep. 2018;40:11-16. doi: 10.1007/8904_2017_53. Epub 2017 Sep 9. JIMD Rep. 2018. PMID: 28887793 Free PMC article.
-
Similarity of Phenotype in Three Male Patients With the c.320A>G Variant in ALG13: Possible Genotype-Phenotype Correlation.Mol Genet Genomic Med. 2024 Sep;12(9):e70010. doi: 10.1002/mgg3.70010. Mol Genet Genomic Med. 2024. PMID: 39311797 Free PMC article.
-
ALG13 X-linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypes.J Inherit Metab Dis. 2021 Jul;44(4):1001-1012. doi: 10.1002/jimd.12378. Epub 2021 Mar 26. J Inherit Metab Dis. 2021. PMID: 33734437 Free PMC article.
-
ALG13-Related Epilepsy: Current Insights and Future Research Directions.Neurochem Res. 2024 Dec 14;50(1):60. doi: 10.1007/s11064-024-04300-y. Neurochem Res. 2024. PMID: 39673593 Review.
Cited by
-
Perspectives on Glycosylation and Its Congenital Disorders.Trends Genet. 2018 Jun;34(6):466-476. doi: 10.1016/j.tig.2018.03.002. Epub 2018 Mar 29. Trends Genet. 2018. PMID: 29606283 Free PMC article. Review.
-
An in vitro assay for enzymatic studies on human ALG13/14 heterodimeric UDP-N-acetylglucosamine transferase.Front Cell Dev Biol. 2022 Sep 19;10:1008078. doi: 10.3389/fcell.2022.1008078. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36200043 Free PMC article.
-
Structural Analysis of the Effect of Asn107Ser Mutation on Alg13 Activity and Alg13-Alg14 Complex Formation and Expanding the Phenotypic Variability of ALG13-CDG.Biomolecules. 2022 Mar 4;12(3):398. doi: 10.3390/biom12030398. Biomolecules. 2022. PMID: 35327592 Free PMC article.
-
Long-term outcomes in ALG13-Congenital Disorder of Glycosylation.Am J Med Genet A. 2023 Jun;191(6):1626-1631. doi: 10.1002/ajmg.a.63179. Epub 2023 Mar 17. Am J Med Genet A. 2023. PMID: 36930724 Free PMC article.
-
De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies.Am J Hum Genet. 2016 Aug 4;99(2):287-98. doi: 10.1016/j.ajhg.2016.06.003. Epub 2016 Jul 28. Am J Hum Genet. 2016. PMID: 27476654 Free PMC article.
References
-
- Bissar-Tadmouri N, Donahue WL, Al-Gazali L, Nelson SF, Bayrak-Toydemir P, Kantarci S. X chromosome exome sequencing reveals a novel ALG13 mutation in a nonsyndromic intellectual disability family with multiple affected male siblings. Am J Med Genet A. 2014;164A:164–169. doi: 10.1002/ajmg.a.36233. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases